Hartley Taylor

Julie, Anne & the team at Hartley Taylor Medical Comms. Register now on-line for CPD Haematology medical seminars that are funded by multiple industry partners

[Hartley Taylor @HT_Medical]

Looking forward to welcoming Dr Melanie Hagen (Erlangen) on LICATS and Dr Johanna Richter (Hamburg) on MS and MG to speak on the CAR T in Autoimmune Diseases programme Friday 19th Sept in London. Places available for in-person or virtual. https://t.co/qBqZRSecs8 @drclaireroddie

[Hartley Taylor @HT_Medical]

Who would like a place at the next UCLH CAR-T for Autoimmune Conditions Update Day - Friday 19th Sept
with @drclaireroddie @uclh ... take a look at the programme - London venue and virtual option https://t.co/qBqZRSdECA

[Hartley Taylor @HT_Medical]

25 years of Hartley Taylor
Thank you to everyone that has supported us over the years. We are really proud to work with such lovely people

[EBMT Nurses @TheEBMT_Nurses]

Discover Michelle Kenyon's End of Year message reflecting on this extraordinary 2024 for the EBMT Nurses Group! 🎉 So many milestones to celebrate, and more to look forward to in 2025 - together, we continue making a difference! 🙏 Read the full article ⬇️
https://t.co/Ame5qtGF59

[Hartley Taylor @HT_Medical]

CAR T for Autoimmune Diseases with speakers: Richard Furie USA, Jeremias Motte Germany, Pere Barba, Spain. UK rheumatologists /neurologists come & join the UCLH Masterclass on 27th Sept (hybrid). Register via Hartley Taylor. Programme here https://t.co/DYdPRJNIQD @drclaireroddie

[Hartley Taylor @HT_Medical]

CAR T for Autoimmune Diseases with speakers: Richard Furie USA, Jeremias Motte Germany, Pere Barba, Spain. UK rheumatologists /neurologists come & join the UCLH Masterclass on 27th Sept (hybrid). Register via Hartley Taylor. Programme here https://t.co/DYdPRJNIQD @drclaireroddie

[Hartley Taylor @HT_Medical]

Saying thank you really isn’t enough praise for the effort the 22 people faculty put into their talks over the last 2 days. Such informative, well structured presentations on latest data in context of clinical application. Just brilliant 2 days …

[Hartley Taylor @HT_Medical]

End of Day 1 Haematology Highlights. Girls off for a well earned glass of wine. Day 2 at the Cavendish is Lymphoma and CLL. Register on the day if you fancy an update on EHA

[Hartley Taylor @HT_Medical]

What a day in Belfast! Thank you everyone for supporting the day with excellent sessions. Tim, Wendy, Eleni, Sally and Charlotte who left for flights made a wonderful haematology faculty with these lovely people in the picture. Special thanks to the Dublin team 😁

[Hartley Taylor @HT_Medical]

@SimonJWoodUK @MasterChefUK @BBCiPlayer Nice to know. Glad to hear you are doing so well. Love the food in Wood Manchester 👍

[Hartley Taylor @HT_Medical]

UCLH CAR T Masterclass in ALL. 15th May in London. Places still available for on-site or as hybrid option. See programme https://t.co/2V0hm5vsuZ and registration link https://t.co/FTSsgnHt2h. #CART #ALL @drclaireroddie

[Satyen Gohil @SatyenGohil]

Come join us at UCLH, Great opportunity to work at one of the biggest haematology centres in the UK, working with some of the nicest people in trials @DrRakeshPopat @ONions_Jen & William Townsend

[Graham Collins @graham74GC]

So important to remember infection is leading cause if non-relapse mortality post CAR. Real need to standardise approach to prophylaxis in evidence based way. #lymsm @HT_Medical

[George Mikhaeel @GeorgeMikhaeel]

Fantastic and entertaining talk by Dr Dan Hodson on ctDNA in 3rd UK cellular therapy forum. It is not really a "simple blood test" but still very promising. @HT_Medical #lymphoma

[Graham Collins @graham74GC]

Subklewe - great talk on CAR T haematotox. The ICAHT!
• no data that early GCSF impacts on toxicities
• GCSF refractory cases need extended workup
• ‘rescue’ with previously save auto stem cells feasible and safe
• can predict risk on D1 of LD
#lymsm @HT_Medical

[Graham Collins @graham74GC]

PTLD and CAR-T. @CwynKate.
Very small amount of data for EBV neg cases. Mixed approach to handing immunosuppression. Responses reasonably good but durability unclear. MDT planning & assessment / optimisation prior to infusion is key for this group. #lymsm @HT_Medical

[Hartley Taylor @HT_Medical]

@profghjackson @MyelomaUK You give so much back to patients in so many ways Graham and colleagues. Good luck to all the team of riders @MyelomaUK

[Hartley Taylor @HT_Medical]

What’s new in haematological malignancies will also cover AML, myeloma, lymphoma, MF, and CAR T. Nearly full now…

[RC of Pathologists @RCPath]

Are you interested in finding out more about acute lymphoblastic leukemia (ALL)?

Join the event @HT_Medical on 11 Mar 2024 09:00 - 17:30 for 6 #CPD credits.

Register https://t.co/wHV6fYRmup #pathology

[Gordon Cook @profBigG]

A great cause and worthy of your great effort. Sorry I won’t be with you this year.

[RC of Pathologists @RCPath]

The UK north myeloma forum @HT_Medical aims to bring together clinicians and AHPs working in myeloma to disseminate national and international data.

This event will be held on Tues 5 March 2024 12.30–18.30pm for 4 #CPD credits.

Register here: https://t.co/D4As2HiWPB #pathology